Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics
Nina N Hosmane, Kyungyoon J Kwon, Katherine M Bruner, Adam A Capoferri, Subul Beg, Daniel I S Rosenbloom, Brandon F Keele, Ya-Chi Ho, Janet D Siliciano, Robert F Siliciano, Nina N Hosmane, Kyungyoon J Kwon, Katherine M Bruner, Adam A Capoferri, Subul Beg, Daniel I S Rosenbloom, Brandon F Keele, Ya-Chi Ho, Janet D Siliciano, Robert F Siliciano
Abstract
A latent reservoir for HIV-1 in resting CD4+ T lymphocytes precludes cure. Mechanisms underlying reservoir stability are unclear. Recent studies suggest an unexpected degree of infected cell proliferation in vivo. T cell activation drives proliferation but also reverses latency, resulting in productive infection that generally leads to cell death. In this study, we show that latently infected cells can proliferate in response to mitogens without producing virus, generating progeny cells that can release infectious virus. Thus, assays relying on one round of activation underestimate reservoir size. Sequencing of independent clonal isolates of replication-competent virus revealed that 57% had env sequences identical to other isolates from the same patient. Identity was confirmed by full-genome sequencing and was not attributable to limited viral diversity. Phylogenetic and statistical analysis suggested that identical sequences arose from in vivo proliferation of infected cells, rather than infection of multiple cells by a dominant viral species. The possibility that much of the reservoir arises by cell proliferation presents challenges to cure.
© 2017 Hosmane et al.
Figures
References
- Abram M.E., Ferris A.L., Shao W., Alvord W.G., and Hughes S.H.. 2010. Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J. Virol. 84:9864–9878. 10.1128/JVI.00915-10
- Anderson A.C., Joller N., and Kuchroo V.K.. 2016. Immunity. 44:989–1004. 10.1016/j.immuni.2016.05.001
- Archin N.M., Liberty A.L., Kashuba A.D., Choudhary S.K., Kuruc J.D., Crooks A.M., Parker D.C., Anderson E.M., Kearney M.F., Strain M.C., et al. . 2012. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 487:482–485. 10.1038/nature11286
- Bailey J.R., Sedaghat A.R., Kieffer T., Brennan T., Lee P.K., Wind-Rotolo M., Haggerty C.M., Kamireddi A.R., Liu Y., Lee J., et al. . 2006. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J. Virol. 80:6441–6457. 10.1128/JVI.00591-06
- Banga R., Procopio F.A., Noto A., Pollakis G., Cavassini M., Ohmiti K., Corpataux J.M., de Leval L., Pantaleo G., and Perreau M.. 2016. PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nat. Med. 22:754–761. 10.1038/nm.4113
- Blazkova J., Trejbalova K., Gondois-Rey F., Halfon P., Philibert P., Guiguen A., Verdin E., Olive D., Van Lint C., Hejnar J., and Hirsch I.. 2009. CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 5:e1000554 10.1371/journal.ppat.1000554
- Boritz E.A., Darko S., Swaszek L., Wolf G., Wells D., Wu X., Henry A.R., Laboune F., Hu J., Ambrozak D., et al. . 2016. Multiple origins of virus persistence during natural control of HIV infection. Cell. 166:1004–1015. 10.1016/j.cell.2016.06.039
- Bosque A., Famiglietti M., Weyrich A.S., Goulston C., and Planelles V.. 2011. Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. PLoS Pathog. 7:e1002288 10.1371/journal.ppat.1002288
- Brodin J., Zanini F., Thebo L., Lanz C., Bratt G., Neher R.A., and Albert J.. 2016. Establishment and stability of the latent HIV-1 DNA reservoir. eLife. 5:e18889 10.7554/eLife.18889
- Bruner K.M., Murray A.J., Pollack R.A., Soliman M.G., Laskey S.B., Capoferri A.A., Lai J., Strain M.C., Lada S.M., Hoh R., et al. . 2016. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat. Med. 22:1043–1049. 10.1038/nm.4156
- Buzon M.J., Sun H., Li C., Shaw A., Seiss K., Ouyang Z., Martin-Gayo E., Leng J., Henrich T.J., Li J.Z., et al. . 2014. HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat. Med. 20:139–142. 10.1038/nm.3445
- Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F.A., Yassine-Diab B., Boucher G., Boulassel M.R., Ghattas G., Brenchley J.M., et al. . 2009. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15:893–900. 10.1038/nm.1972
- Chun T.W., Finzi D., Margolick J., Chadwick K., Schwartz D., and Siliciano R.F.. 1995. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1:1284–1290. 10.1038/nm1295-1284
- Chun T.W., Carruth L., Finzi D., Shen X., DiGiuseppe J.A., Taylor H., Hermankova M., Chadwick K., Margolick J., Quinn T.C., et al. . 1997a Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 387:183–188. 10.1038/387183a0
- Chun T.W., Stuyver L., Mizell S.B., Ehler L.A., Mican J.A., Baseler M., Lloyd A.L., Nowak M.A., and Fauci A.S.. 1997b Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA. 94:13193–13197. 10.1073/pnas.94.24.13193
- Cohn L.B., Silva I.T., Oliveira T.Y., Rosales R.A., Parrish E.H., Learn G.H., Hahn B.H., Czartoski J.L., McElrath M.J., Lehmann C., et al. . 2015. HIV-1 integration landscape during latent and active infection. Cell. 160:420–432. 10.1016/j.cell.2015.01.020
- Crooks A.M., Bateson R., Cope A.B., Dahl N.P., Griggs M.K., Kuruc J.D., Gay C.L., Eron J.J., Margolis D.M., Bosch R.J., and Archin N.M.. 2015. Precise quantitation of the latent HIV-1 reservoir: Implications for eradication strategies. J. Infect. Dis. 212:1361–1365. 10.1093/infdis/jiv218
- Deeks S.G., Lewin S.R., Ross A.L., Ananworanich J., Benkirane M., Cannon P., Chomont N., Douek D., Lifson J.D., Lo Y.R., et al. International AIDS Society Towards a Cure Working Group . 2016. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat. Med. 22:839–850. 10.1038/nm.4108
- DeHart J.L., Zimmerman E.S., Ardon O., Monteiro-Filho C.M., Argañaraz E.R., and Planelles V.. 2007. HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. Virol. J. 4:57 10.1186/1743-422X-4-57
- Eriksson S., Graf E.H., Dahl V., Strain M.C., Yukl S.A., Lysenko E.S., Bosch R.J., Lai J., Chioma S., Emad F., et al. . 2013. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 9:e1003174 10.1371/journal.ppat.1003174
- Ewens W.J. 1972. The sampling theory of selectively neutral alleles. Theor. Popul. Biol. 3:87–112. 10.1016/0040-5809(72)90035-4
- Finzi D., Hermankova M., Pierson T., Carruth L.M., Buck C., Chaisson R.E., Quinn T.C., Chadwick K., Margolick J., Brookmeyer R., et al. . 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science. 278:1295–1300. 10.1126/science.278.5341.1295
- Finzi D., Blankson J., Siliciano J.D., Margolick J.B., Chadwick K., Pierson T., Smith K., Lisziewicz J., Lori F., Flexner C., et al. . 1999. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512–517. 10.1038/8394
- Halper-Stromberg A., Lu C.L., Klein F., Horwitz J.A., Bournazos S., Nogueira L., Eisenreich T.R., Liu C., Gazumyan A., Schaefer U., et al. . 2014. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell. 158:989–999. 10.1016/j.cell.2014.07.043
- Han Y., Lassen K., Monie D., Sedaghat A.R., Shimoji S., Liu X., Pierson T.C., Margolick J.B., Siliciano R.F., and Siliciano J.D.. 2004. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 78:6122–6133. 10.1128/JVI.78.12.6122-6133.2004
- Han Y., Lin Y.B., An W., Xu J., Yang H.C., O’Connell K., Dordai D., Boeke J.D., Siliciano J.D., and Siliciano R.F.. 2008. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe. 4:134–146. 10.1016/j.chom.2008.06.008
- Hatziioannou T., Del Prete G.Q., Keele B.F., Estes J.D., McNatt M.W., Bitzegeio J., Raymond A., Rodriguez A., Schmidt F., Mac Trubey C., et al. . 2014. HIV-1–induced AIDS in monkeys. Science. 344:1401–1405. 10.1126/science.1250761
- Ho D.D., Neumann A.U., Perelson A.S., Chen W., Leonard J.M., and Markowitz M.. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:123–126. 10.1038/373123a0
- Ho Y.C., Shan L., Hosmane N.N., Wang J., Laskey S.B., Rosenbloom D.I., Lai J., Blankson J.N., Siliciano J.D., and Siliciano R.F.. 2013. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell. 155:540–551. 10.1016/j.cell.2013.09.020
- Hrecka K., Gierszewska M., Srivastava S., Kozaczkiewicz L., Swanson S.K., Florens L., Washburn M.P., and Skowronski J.. 2007. Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc. Natl. Acad. Sci. USA. 104:11778–11783. 10.1073/pnas.0702102104
- Imamichi H., Natarajan V., Adelsberger J.W., Rehm C.A., Lempicki R.A., Das B., Hazen A., Imamichi T., and Lane H.C.. 2014. Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus. AIDS. 28:1091–1099. 10.1097/QAD.0000000000000223
- Imamichi H., Dewar R.L., Adelsberger J.W., Rehm C.A., O’Doherty U., Paxinos E.E., Fauci A.S., and Lane H.C.. 2016. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc. Natl. Acad. Sci. USA. 113:8783–8788. 10.1073/pnas.1609057113
- Jordan A., Bisgrove D., and Verdin E.. 2003. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22:1868–1877. 10.1093/emboj/cdg188
- Jowett J.B., Planelles V., Poon B., Shah N.P., Chen M.L., and Chen I.S.. 1995. The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69:6304–6313.
- Kumar S., Stecher G., and Tamura K.. 2016. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol. Biol. Evol. 33:1870–1874. 10.1093/molbev/msw054
- Laird G.M., Eisele E.E., Rabi S.A., Lai J., Chioma S., Blankson J.N., Siliciano J.D., and Siliciano R.F.. 2013. Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay. PLoS Pathog. 9:e1003398 10.1371/journal.ppat.1003398
- Laird G.M., Rosenbloom D.I., Lai J., Siliciano R.F., and Siliciano J.D.. 2016. Measuring the frequency of latent HIV-1 in resting CD4+ T cells using a limiting dilution coculture assay. Methods Mol. Biol. 1354:239–253. 10.1007/978-1-4939-3046-3_16
- Laskey S.B., Pohlmeyer C.W., Bruner K.M., and Siliciano R.F.. 2016. Evaluating clonal expansion of HIV-infected cells: Optimization of PCR strategies to predict clonality. PLoS Pathog. 12:e1005689 10.1371/journal.ppat.1005689
- Lenasi T., Contreras X., and Peterlin B.M.. 2008. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell Host Microbe. 4:123–133. 10.1016/j.chom.2008.05.016
- Lewinski M.K., Bisgrove D., Shinn P., Chen H., Hoffmann C., Hannenhalli S., Verdin E., Berry C.C., Ecker J.R., and Bushman F.D.. 2005. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J. Virol. 79:6610–6619. 10.1128/JVI.79.11.6610-6619.2005
- Li H., Bar K.J., Wang S., Decker J.M., Chen Y., Sun C., Salazar-Gonzalez J.F., Salazar M.G., Learn G.H., Morgan C.J., et al. . 2010. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog. 6:e1000890 10.1371/journal.ppat.1000890
- Lorenzi J.C., Cohen Y.Z., Cohn L.B., Kreider E.F., Barton J.P., Learn G.H., Oliveira T., Lavine C.L., Horwitz J.A., Settler A., et al. . 2016. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA. Proc. Natl. Acad. Sci. USA. 113:E7908–E7916. 10.1073/pnas.1617789113
- Maldarelli F., Kearney M., Palmer S., Stephens R., Mican J., Polis M.A., Davey R.T., Kovacs J., Shao W., Rock-Kress D., et al. . 2013. HIV populations are large and accumulate high genetic diversity in a nonlinear fashion. J. Virol. 87:10313–10323. 10.1128/JVI.01225-12
- Maldarelli F., Wu X., Su L., Simonetti F.R., Shao W., Hill S., Spindler J., Ferris A.L., Mellors J.W., Kearney M.F., et al. . 2014. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science. 345:179–183. 10.1126/science.1254194
- Mansky L.M., and Temin H.M.. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087–5094.
- Nickle D.C., Jensen M.A., Shriner D., Brodie S.J., Frenkel L.M., Mittler J.E., and Mullins J.I.. 2003. Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments. J. Virol. 77:5540–5546. 10.1128/JVI.77.9.5540-5546.2003
- Pearson R., Kim Y.K., Hokello J., Lassen K., Friedman J., Tyagi M., and Karn J.. 2008. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J. Virol. 82:12291–12303. 10.1128/JVI.01383-08
- Razooky B.S., Pai A., Aull K., Rouzine I.M., and Weinberger L.S.. 2015. A hardwired HIV latency program. Cell. 160:990–1001. 10.1016/j.cell.2015.02.009
- Richman D.D., Margolis D.M., Delaney M., Greene W.C., Hazuda D., and Pomerantz R.J.. 2009. The challenge of finding a cure for HIV infection. Science. 323:1304–1307. 10.1126/science.1165706
- Romani B., and Cohen E.A.. 2012. Lentivirus Vpr and Vpx accessory proteins usurp the cullin4-DDB1 (DCAF1) E3 ubiquitin ligase. Curr. Opin. Virol. 2:755–763. 10.1016/j.coviro.2012.09.010
- Rosenbloom D.I., Elliott O., Hill A.L., Henrich T.J., Siliciano J.M., and Siliciano R.F.. 2015. Designing and interpreting limiting dilution assays: General principles and applications to the latent reservoir for human immunodeficiency virus-1. Open Forum Infect. Dis. 2:ofv123 10.1093/ofid/ofv123
- Sakai K., Dimas J., and Lenardo M.J.. 2006. The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest. Proc. Natl. Acad. Sci. USA. 103:3369–3374. 10.1073/pnas.0509417103
- Schröder A.R., Shinn P., Chen H., Berry C., Ecker J.R., and Bushman F.. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell. 110:521–529. 10.1016/S0092-8674(02)00864-4
- Schröfelbauer B., Hakata Y., and Landau N.R.. 2007. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc. Natl. Acad. Sci. USA. 104:4130–4135. 10.1073/pnas.0610167104
- Scripture-Adams D.D., Brooks D.G., Korin Y.D., and Zack J.A.. 2002. Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype. J. Virol. 76:13077–13082. 10.1128/JVI.76.24.13077-13082.2002
- Shan L., Yang H.C., Rabi S.A., Bravo H.C., Shroff N.S., Irizarry R.A., Zhang H., Margolick J.B., Siliciano J.D., and Siliciano R.F.. 2011. Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model. J. Virol. 85:5384–5393. 10.1128/JVI.02536-10
- Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., et al. . 1999. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73:10489–10502.
- Siliciano J.D., and Siliciano R.F.. 2005. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol. Biol. 304:3–15.
- Siliciano J.D., Kajdas J., Finzi D., Quinn T.C., Chadwick K., Margolick J.B., Kovacs C., Gange S.J., and Siliciano R.F.. 2003. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9:727–728. 10.1038/nm880
- Simonetti F.R., Sobolewski M.D., Fyne E., Shao W., Spindler J., Hattori J., Anderson E.M., Watters S.A., Hill S., Wu X., et al. . 2016. Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. Proc. Natl. Acad. Sci. USA. 113:1883–1888. 10.1073/pnas.1522675113
- Soriano-Sarabia N., Bateson R.E., Dahl N.P., Crooks A.M., Kuruc J.D., Margolis D.M., and Archin N.M.. 2014. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells. J. Virol. 88:14070–14077. 10.1128/JVI.01900-14
- Stewart S.A., Poon B., Jowett J.B., and Chen I.S.. 1997. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:5579–5592.
- Stewart S.A., Poon B., Song J.Y., and Chen I.S.. 2000. Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J. Virol. 74:3105–3111. 10.1128/JVI.74.7.3105-3111.2000
- Strain M.C., Günthard H.F., Havlir D.V., Ignacio C.C., Smith D.M., Leigh-Brown A.J., Macaranas T.R., Lam R.Y., Daly O.A., Fischer M., et al. . 2003. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc. Natl. Acad. Sci. USA. 100:4819–4824. 10.1073/pnas.0736332100
- Tamura K., Nei M., and Kumar S.. 2004. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. USA. 101:11030–11035. 10.1073/pnas.0404206101
- Tobin N.H., Learn G.H., Holte S.E., Wang Y., Melvin A.J., McKernan J.L., Pawluk D.M., Mohan K.M., Lewis P.F., Mullins J.I., and Frenkel L.M.. 2005. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J. Virol. 79:9625–9634. 10.1128/JVI.79.15.9625-9634.2005
- Tyagi M., Pearson R.J., and Karn J.. 2010. Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J. Virol. 84:6425–6437. 10.1128/JVI.01519-09
- Vandergeeten C., Fromentin R., DaFonseca S., Lawani M.B., Sereti I., Lederman M.M., Ramgopal M., Routy J.P., Sékaly R.P., and Chomont N.. 2013. Interleukin-7 promotes HIV persistence during antiretroviral therapy. Blood. 121:4321–4329. 10.1182/blood-2012-11-465625
- von Stockenstrom S., Odevall L., Lee E., Sinclair E., Bacchetti P., Killian M., Epling L., Shao W., Hoh R., Ho T., et al. . 2015. Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV type 1 DNA pool during effective HIV therapy. J. Infect. Dis. 212:596–607. 10.1093/infdis/jiv092
- Wagner T.A., McLaughlin S., Garg K., Cheung C.Y., Larsen B.B., Styrchak S., Huang H.C., Edlefsen P.T., Mullins J.I., and Frenkel L.M.. 2014. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science. 345:570–573. 10.1126/science.1256304
- Wang F.X., Xu Y., Sullivan J., Souder E., Argyris E.G., Acheampong E.A., Fisher J., Sierra M., Thomson M.M., Najera R., et al. . 2005. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J. Clin. Invest. 115:128–137. 10.1172/JCI200522574
- Wei X., Ghosh S.K., Taylor M.E., Johnson V.A., Emini E.A., Deutsch P., Lifson J.D., Bonhoeffer S., Nowak M.A., Hahn B.H., et al. . 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:117–122. 10.1038/373117a0
- Wong J.K., Hezareh M., Günthard H.F., Havlir D.V., Ignacio C.C., Spina C.A., and Richman D.D.. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 278:1291–1295. 10.1126/science.278.5341.1291
Source: PubMed